Short and long-term exposure of CNS cell lines to BPA-f a radiosensitizer for boron neutron capture therapy: safety dose evaluation by a battery of cytotoxicity tests.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Neurotoxicology

• Publication date

  2013-03-01

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1016/j.neuro.2012.12.006PMID 23261588
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of chitosan multilayers encapsulation on controlled release performance of drug-loaded superparamagnetic alginate nanoparticles

  2012cited by this paper
• Stable and efficient delivery of docetaxel by micelle-encapsulation using a tripodal cyclotriphosphazene amphiphile.

  2012cited by this paper
• Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase I/II trial.

  2012cited by this paper
• Nanoencapsulated anti-CK2 small molecule drug or siRNA specifically targets malignant cancer but not benign cells.

  2012cited by this paper
• Boron neutron capture in prostate cancer cells.

  2012cited by this paper
• Studies for the application of boron neutron capture therapy to the treatment of differentiated thyroid cancer.

  2011cited by this paper
• Evaluation of BPA uptake in clear cell sarcoma (CCS) in vitro and development of an in vivo model of CCS for BNCT studies.

  2011cited by this paper
• L-boronophenylalanine-mediated boron neutron capture therapy for malignant glioma progressing after external beam radiation therapy: a Phase I study.

  2011cited by this paper
• Clinical results of boron neutron capture therapy (BNCT) for glioblastoma.

  2011cited by this paper
• Early effect of boron neutron capture therapy mediated by boronophenylalanine (BPA-BNCT) on mast cells in premalignant tissue and tumors of the hamster cheek pouch.

  2010cited by this paper
• Effectiveness of boron neutron capture therapy for recurrent head and neck malignancies.

  2009cited by this paper
• Extra-corporeal liver BNCT for the treatment of diffuse metastases: what was learned and what is still to be learned.

  2009cited by this paper
• Biological evaluation of boronated unnatural amino acids as new boron carriers.

  2009cited by this paper
• Carborane derivatives loaded into liposomes as efficient delivery systems for boron neutron capture therapy.

  2009cited by this paper
• L-amino acid transporter-1 and boronophenylalanine-based boron neutron capture therapy of human brain tumors.

  2009cited by this paper
• Feasibility study on the utilization of boron neutron capture therapy (BNCT) in a rat model of diffuse lung metastases.

  2009cited by this paper
• Selective uptake of p-boronophenylalanine by osteosarcoma cells for boron neutron capture therapy.

  2009cited by this paper
• Boronophenylalanine uptake in C6 glioma model is dramatically increased by L-DOPA preloading.

  2009cited by this paper
• A new approach to the toxicity testing of carbon-based nanomaterials--the clonogenic assay.

  2007cited by this paper
• Boron neutron capture therapy in cancer: past, present and future.

  2007cited by this paper
• Apoptosis: A Review of Programmed Cell Death

  2007cited by this paper
• Cell death by necrosis: towards a molecular definition.

  2007cited by this paper
• Feasibility of boron neutron capture therapy (BNCT) for malignant pleural mesothelioma from a viewpoint of dose distribution analysis.

  2006cited by this paper
• Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).

  2006cited by this paper
• Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects

  2005cited by this paper
• Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.

  2005cited by this paper
• First BNCT treatment of a skin melanoma in Argentina: dosimetric analysis and clinical outcome.

  2004cited by this paper
• Clinical Review of the Japanese Experience with Boron Neutron Capture Therapy and A Proposed Strategy Using Epithermal Neutron Beams

  2004cited by this paper
• Assessment of the Results from the Phase I/II Boron Neutron Capture Therapy Trials at the Brookhaven National Laboratory from a Clinician's Point of View

  2004cited by this paper
• Clinical review of the japanese experience with boron neutron capture therapy and a proposed strategy using epithermal neutron beams

  2003cited by this paper
• Boron neutron capture therapy of brain tumors: clinical trials at the Finnish facility using boronophenylalanine

  2003cited by this paper
• Assessment of the results from the phase I/II boron neutron capture therapy trials at the Brookhaven National Laboratory from a clinician’s point of view

  2003cited by this paper
• Neutron capture therapy of intracerebral melanoma: enhanced survival and cure after blood-brain barrier opening to improve delivery of boronophenylalanine.

  2002cited by this paper
• Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.

  2001cited by this paper
• TA1/LAT-1/CD98 Light Chain and System L Activity, but Not 4F2/CD98 Heavy Chain, Respond to Arginine Availability in Rat Hepatic Cells

  2000cited by this paper
• Mechanisms of Transport of p-Borono-Phenylalanine through the Cell Membrane In Vitro

  2000cited by this paper
• Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.

  2000cited by this paper
• Effect of Dose and Infusion Time on the Delivery of p-boronophenylalanine for Neutron Capture Therapy

  1999cited by this paper
• Mitochondria and apoptosis.

  1998cited by this paper
• Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity.

  1998cited by this paper
• Ion microscopy imaging of 10B from p-boronophenylalanine in a brain tumor model for boron neutron capture therapy.

  1996cited by this paper
• Expression of a highly conserved oncofetal gene, TA1/E16, in human colon carcinoma and other primary cancers: homology to Schistosoma mansoni amino acid permease and Caenorhabditis elegans gene products.

  1996cited by this paper
• A nude rat model for neutron capture therapy of human intracerebral melanoma.

  1994cited by this paper
• Preloading with L-tyrosine increases the uptake of boronophenylalanine in mouse melanoma cells.

  1994cited by this paper
• [Neutron capture therapy for cancer].

  1994cited by this paper
• Boron Neutron Capture Therapy of Glioblastoma Multiforme Using the p-Boronophenylalanine-Fructose Complex and Epithermal Neutrons

  1994cited by this paper
• New thermal neutron capture therapy for malignant melanoma: melanogenesis-seeking 10B molecule-melanoma cell interaction from in vitro to first clinical trial.

  1989cited by this paper
• Treatment of malignant melanoma by single thermal neutron capture therapy with melanoma-seeking 10B-compound.

  1989cited by this paper
• D‐1 Dopaminergic and β‐Adrenergic Stimulation of Adenylate Cyclase in a Clone Derived from the Human Astrocytoma Cell Line G‐CCM

  1986cited by this paper

• In Vivo Application of Carboranes for Boron Neutron Capture Therapy (BNCT): Structure, Formulation and Analytical Methods for Detection

  2023cites this paper
• Laser-Synthesized Elemental Boron Nanoparticles for Efficient Boron Neutron Capture Therapy

  2023cites this paper
• Antiproliferative Activity of Aminobenzylnaphthols Deriving from the Betti Reaction

  2022cites this paper
• Boron Accumulation in Brain Tumor Cells through Boc-Protected Tryptophan as a Carrier for Boron Neutron Capture Therapy.

  2020cites this paper
• ЦИТОПАТИЧЕСКИЕ ЭФФЕКТЫ БОР-НЕЙТРОНОЗАХВАТНОЙ ТЕРАПИИ НА УСКОРИТЕЛЬНОМ ИСТОЧНИКЕ ЭПИТЕПЛОВЫХ НЕЙТРОНОВ ДЛЯ КУЛЬТУРЫ КЛЕТОК ГЛИОБЛАСТОМЫ ЧЕЛОВЕКА

  2019cites this paper
• Human neuronal cell based assay: A new in vitro model for toxicity evaluation of ciguatoxin.

  2017cites this paper
• Cytotoxicity and proliferative capacity impairment induced on human brain cell cultures after short‐ and long‐term exposure to magnetite nanoparticles

  2017cites this paper
• Boron’s journey: advances in the study and application of pharmacokinetics

  2017cites this paper
• Current data regarding the structure-toxicity relationship of boron-containing compounds.

  2016cites this paper
• Disruption of motor behavior and injury to the CNS induced by 3-thienylboronic acid in mice.

  2016cites this paper
• An integrated in Vitro and in Vivo Testing Approach to Assess Pulmonary Toxicity of Engineered Cadmium-Doped Silica Nanoparticles

  2015cites this paper
• Effect of Boric Acid Supplementation on the Expression of BDNF in African Ostrich Chick Brain

  2015cites this paper
• Comparative cellular toxicity of titanium dioxide nanoparticles on human astrocyte and neuronal cells after acute and prolonged exposure.

  2015cites this paper
• Enhanced toxicity of silver nanoparticles in transgenic Caenorhabditis elegans expressing amyloidogenic proteins

  2015cites this paper
• Assessment of Cellular Responses after Short- and Long-Term Exposure to Silver Nanoparticles in Human Neuroblastoma (SH-SY5Y) and Astrocytoma (D384) Cells

  2014cites this paper
• Boron-containing compounds: chemico-biological properties and expanding medicinal potential in prevention, diagnosis and therapy

  2014cites this paper
• Boron-containing acids: preliminary evaluation of acute toxicity and access to the brain determined by Raman scattering spectroscopy.

  2014cites this paper
• Blood-brain barrier (BBB) toxicity and permeability assessment after L-(4-¹⁰Boronophenyl)alanine, a conventional B-containing drug for boron neutron capture therapy, using an in vitro BBB model.

  2014influential citation